Pharmacokinetic Profile of Flosequinan in Patients with Compromised Renal Function
- 1 March 1993
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 82 (3) , 282-285
- https://doi.org/10.1002/jps.2600820313
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Positive Inotropy Contributes to the Hemodynamic Mechanism of Action of Flosequinan (BTS 49465) in the Intact DogJournal of Cardiovascular Pharmacology, 1990
- Positive Inotropic and Hemodynamic Properties of Flosequinan, a New Vasodilator, and a Sulfone MetaboliteJournal of Cardiovascular Pharmacology, 1989
- Central and regional hemodynamic effects of flosequinan for congestive heart failureThe American Journal of Cardiology, 1989
- The effect of flosequinan in patients with acute-onset heart failure complicating acute myocardial infarction.Japanese Heart Journal, 1989
- Simplified high-performance liquid chromatographic determination of flosequinan and its metabolite in plasma, serum and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ, 1988
- Cumulative Hemodynamic Response to Short-Term Treatment with Flosequinan (BTS 49465), a New Direct-Acting Vasodilator Drug, in Severe Chronic Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1988
- Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failureAmerican Heart Journal, 1987
- The pharmacokinetics and haemodynamics of BTS 49465 and its major metabolite in healthy volunteersEuropean Journal of Clinical Pharmacology, 1985
- Standardized Methods for Comparison of SphygmomanometersJournal Of Hypertension, 1984